Mirtazapine (Remeron), Serum or Plasma
Order Name
Mirtazapine
Test Number: 6905779
Revision Date 10/20/2022
Test Number: 6905779
Revision Date 10/20/2022
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Mirtazapine (Remeron), Serum or Plasma
|
High-pressure liquid chromatography (HPLC) with fluorometric detection | 17283-3 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 2 mL (0.5 mL) | Serum | Clot Activator (Red Top, No-Gel) | Room Temperature |
| Instructions | Specimen Type: Red-top tube OR green-top (heparin) tube. Gel-barrier tubes are NOT recommended. Specimen Storage: SUBMISSION/TRANSPORT (<3 days): Room Temperature. For storage beyond three days, specimen should be refrigerated or frozen. Specimen Collection: Serum or plasma should be separated from cells within two hours of venipuncture. Submit serum or plasma in a plastic transport tube. Special Instructions: Testing referred to MedTox Laboratories Inc MX#434 |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 10-14 days |
| CPT Code(s) | 80299 |
| Lab Section | Reference Lab |